News

Pharming is entitled to request Yorkville Advisors Global Master (YA Global) to subscribe to and purchase newly issued shares in regular tranches of up to E400,000 per tranche.

The company recorded operating income of $0.9 million for the three-month period, compared to $2.7 million for the prior-year period. In the company’s Laboratory Segment, revenues from drugs-of-abuse

Centocor Ortho Biotech, a wholly-owned subsidiary of Johnson & Johnson, and Schering-Plough have announced that Health Canada has granted approval of Simponi as a once-monthly, subcutaneous therapy for

The research collaboration involves the preclinical application of ImmunoVaccine Technologies’s (IVT’s) DepoVax vaccine formulation to anthrax antigens to explore new methods to prevent, prepare for, and respond to

Biomet, a designer, manufacturer and marketer of products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy, has reported a net loss of $478.7m for

Core Essence Orthopaedics, a medical device company, has received 510k regulatory approval from the FDA for Securus, a novel knotless suture anchor system used in minimally invasive, arthroscopic

Azur will market Elestrin to estrogen prescribing physicians, comprised mostly of gynecologists. Azur recently increased its women’s health and urology sales force to 65 people to support the

The study has commenced recruiting patients in the US with sites in the UK, Germany and Australia due to open later in 2009. The OPTiM trial is a

Cardiometabolic Support Network, a team of medical experts, has adopted Cisco WebEx online meetings to deliver advice and support to patients through live, online group meetings with registered